Related Experiment Videos

Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

J Hugosson1, H Lilja, P Lodding

  • 1Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden. jonas.hugosson@vgregion.se

European Urology
|May 8, 2001
PubMed
Summary

No abstract available in PubMed .

Related Concept Videos